Kiniksa Pharmaceuticals International Plc (KNSA)

06:01 AM

Catalyst Funds Management Pty Ltd Takes $493,000 Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

06:01 AM

Nov 20, 2025

Insider Selling: Kiniksa Pharmaceuticals International (NASDAQ:KNSA) COO Sells 12,470 Shares of Stock - MarketBeat

Nov 20, 2025

Nov 20, 2025

SG Americas Securities LLC Acquires 127,126 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Nov 20, 2025

Nov 19, 2025

Kiniksa Pharma COO Tessari sells shares worth $514,224 - Investing.com India

Nov 19, 2025

Nov 19, 2025

Kiniksa Pharma COO Tessari sells shares worth $514,224 By Investing.com - Investing.com UK

Nov 19, 2025

Nov 19, 2025

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Sets New 52-Week HighTime to Buy? - MarketBeat

Nov 19, 2025

Nov 19, 2025

Los Angeles Capital Management LLC Sells 36,570 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Nov 19, 2025

Nov 19, 2025

From Olema To Insmed: Are These High-Flying Biotechs Still Worth Buying? - RTTNews

Nov 19, 2025

Nov 18, 2025

Savant Capital LLC Invests $398,000 in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Nov 18, 2025

Nov 16, 2025

Mark Ragosa Sells 19,900 Shares of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock - MarketBeat

Nov 16, 2025

Nov 15, 2025

Kiniksa Rides ARCALYST Growth To Outpace The S&P 500 - Finimize

Nov 15, 2025

Nov 14, 2025

Exploring High Growth Tech Stocks in the US Market - Yahoo Finance

Nov 14, 2025

Nov 12, 2025

Kiniksa Pharmaceuticals to Present at Jefferies Global Healthcare Conference in London - The Manila Times

Nov 12, 2025

Nov 12, 2025

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Increases 5.3% This Week, Taking Five-year Gains to 166% - 富途牛牛

Nov 12, 2025

Nov 12, 2025

Kiniksa (NASDAQ: KNSA) to present at Jefferies Healthcare Conf.; live webcast Nov. 17 - Stock Titan

Nov 12, 2025

Nov 11, 2025

Connor Clark & Lunn Investment Management Ltd. Has $17.26 Million Holdings in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Nov 11, 2025

Nov 11, 2025

Kiniksa Pharmaceuticals International, plc $KNSA Shares Acquired by Acadian Asset Management LLC - MarketBeat

Nov 11, 2025

Nov 09, 2025

Fox Run Management L.L.C. Buys 24,391 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Nov 09, 2025

Nov 06, 2025

Vanguard Group Inc Reduces Stake in Kiniksa Pharmaceuticals Inte - GuruFocus

Nov 06, 2025

Nov 05, 2025

John Paolini Sells 82,542 Shares of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock - MarketBeat

Nov 05, 2025

Nov 05, 2025

Kiniksa Pharmaceuticals International, plc (KNSA) Q3 Earnings Miss Estimates - MSN

Nov 05, 2025

Nov 05, 2025

We Think Kiniksa Pharmaceuticals International's (NASDAQ:KNSA) Profit Is Only A Baseline For What They Can Achieve - Yahoo Finance

Nov 05, 2025

Nov 04, 2025

Kiniksa Pharmaceuticals CMO Sells Shares - TradingView

Nov 04, 2025

Nov 04, 2025

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Nov 04, 2025

Nov 03, 2025

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 03, 2025

Nov 02, 2025

Y Intercept Hong Kong Ltd Buys New Holdings in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Nov 02, 2025

Nov 01, 2025

Asset Management One Co. Ltd. Boosts Stock Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Nov 01, 2025

Oct 31, 2025

Equities Analysts Offer Predictions for KNSA FY2025 Earnings - MarketBeat

Oct 31, 2025

Oct 31, 2025

Kiniksa raises 2025 ARCALYST sales guidance to $670M-$675M as market penetration grows - MSN

Oct 31, 2025

Oct 30, 2025

Ragosa Mark, CFO of Kiniksa, sells $4100 in KNSA stock By Investing.com - Investing.com Australia

Oct 30, 2025

Oct 30, 2025

Ragosa Mark, CFO of Kiniksa, sells $4100 in KNSA stock - Investing.com

Oct 30, 2025

Oct 30, 2025

[Form 4] Kiniksa Pharmaceuticals International, plc Insider Trading Activity - Stock Titan

Oct 30, 2025

Oct 30, 2025

New Strong Sell Stocks for Oct. 30th - The Globe and Mail

Oct 30, 2025

Oct 30, 2025

Kiniksa: How Category Ownership And Higher Duration Are Translating Into Operating Leverage - Seeking Alpha

Oct 30, 2025

Oct 30, 2025

Goldman Sachs Raises Target Price for Kiniksa Pharmaceuticals (K - GuruFocus

Oct 30, 2025

Oct 29, 2025

Kiniksa Ramps Up Revenue Forecast As ARCALYST Gains Traction - Finimize

Oct 29, 2025

Oct 29, 2025

Kiniksa Pharmaceuticals International’s (KNSA) “Outperform” Rating Reaffirmed at Wedbush - Defense World

Oct 29, 2025

Oct 29, 2025

Kiniksa Pharmaceuticals (KNSA): Assessing Valuation After Strong ARCALYST Growth, Raised Guidance, and FDA Orphan Drug Win - Yahoo! Finance UK

Oct 29, 2025

Oct 29, 2025

Decoding Kiniksa Pharmaceuticals International PLC (KNSA): A Str - GuruFocus

Oct 29, 2025

Oct 28, 2025

Kiniksa Pharmaceuticals International, plc SEC 10-Q Report - TradingView

Oct 28, 2025

Oct 28, 2025

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Sets New 12-Month HighHere's Why - MarketBeat

Oct 28, 2025

Oct 28, 2025

Key Developments in KNSA Revenue Forecasts - GuruFocus

Oct 28, 2025

Oct 28, 2025

Q3 2025 Earnings Call - MarketScreener

Oct 28, 2025

Oct 28, 2025

KNSA Surpasses Revenue Expectations and Updates Sales Forecast - GuruFocus

Oct 28, 2025

Oct 28, 2025

Kiniksa Pharmaceuticals Swings to Q3 Net Income, Revenue Increases - MarketScreener

Oct 28, 2025

Oct 28, 2025

Kiniksa Pharmaceuticals Q3 2025 Earnings: Revenue Surpasses Esti - GuruFocus

Oct 28, 2025